Gamida Cell Ltd

NASDAQ:GMDA   4:00:00 PM EDT
0.04
-0.02 (-39.02%)
7:59:43 PM EDT: $0.04 0.00 (6.09%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)4.79M
Current PEN/A
Forward PE N/A
2yr Forward PE 0.1
See more stats
Estimates Current Quarter
Revenue$1.06 Million
Adjusted EPS-$0.15
See more estimates
10-Day MA$0.26
50-Day MA$0.35
200-Day MA$0.81
See more pivots

Gamida Cell Ltd Stock, NASDAQ:GMDA

116 Huntington Avenue, Givaat Shaul, Boston, Massachusetts 02116
Israel
Phone: +1.617.892.9080
Number of Employees: 148

Description

Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm offers Omidubicel, an investigational product with potential as a life-saving alternative for patients in need of a bone marrow transplant, and a line of modified and unmodified nicotinamide-enabled natural killer cells targeted at solid tumor and hematological malignancies. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Boston, MA.